bullish
Ono 1H FY18 (YE Mar'19) Results - First Glance
416 Views01 Nov 2018 22:50
Key highlights
Brisk Opdivo domestic (+12% to ¥45.4b) and overseas (estimated royalty of ~¥28b, up 63% y-o-y) sales led robust topline growth of...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Ono 1H FY18 (YE Mar'19) Results - First Glance01 Nov 2018
- Opdivo Potential Capped Due to Pricing Pressure and Keytruda Competition17 Jul 2018
- Ono FY17 Earnings - First Glance11 May 2018
- Ono’s Stock Price Decline on Merck’s KN-189 Success18 Apr 2018
x